Where does Alliedinnovative.com rank among its competitors?

Alliedinnovative.com ranks 1019th amongst 1015 active competitors, of which 47 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of Alliedinnovative.com?

Alliedinnovative.com's top competitors include Abcam, Meridian Bioscience and Huwel Life. Among them, BioLamina secured the most recent funding round in April, 2026.

Alliedinnovative.com - 2026 Company Profile & Competitors

Company Details

Developer of technologies for clinical diagnostics, drug screening, and drug delivery. The company focuses on creating novel solutions supported by grants. Key technologies enhance performance in medical tests. The business seeks strategic partnerships to commercialize its innovations.

Key Metrics

Stage

Funding Raised

Ranked

1019^th among 1157 competitors

Similar Companies

Abcam & 1155 more

View Alliedinnovative.com's full profile

Alliedinnovative.com is a funded company.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Alliedinnovative.com include Abcam, Meridian Bioscience and Huwel Life. Here is the list of Top 10 competitors of Alliedinnovative.com, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	76/100
2nd	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
3rd	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	63/100
4th	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	Battery Ventures	61/100
5th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, BDC & 1 others	58/100
6th	Teknova 1996, Hollister (United States), Public	Provider of molecular biology research reagents and kits	-	Cambrian Growth Partners, Telegraph Hill Partners ... & 2 others	56/100
7th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100
8th	PL BioScience 2015, Aachen (Germany), Series A	Manufacturer of human platelet lysate products for cell culture applications	$13M	TechVision Fonds, Brightlands Venture Partners ... & 18 others	55/100
9th	Luminex 1995, Austin (United States), Acquired	Developer of instruments, reagents and kits for clinical diagnostics and life science research	-	Public Health Emergency, National Science Foundation ... & 1 others	55/100
10th	Firefly BioWorks 2009, Cambridge (United States), Acquired	Develops platform to allow multiplexed assays on standard laboratory instrumentation	$3.77M	PBM Capital, Breton Capital Ventures & 3 others	54/100
1019th	Alliedinnovative.com Funding Raised	Developer of technologies for clinical diagnostics, drug screening, and drug delivery	-	-	16/100